Home Stock

Stock Research: Medacta Group

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Medacta Group

SWX:MOVE CH0468525222
40
  • Value
    10
  • Growth
    84
  • Safety
    Safety
    69
  • Combined
    60
  • Sentiment
    30
  • 360° View
    360° View
    40
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Medacta Group SA is a Swiss-based medical device company specializing in orthopedic products and surgical techniques. The company operates in joint replacement, spine surgery, and sports medicine, offering hip, knee, shoulder, and spine products. It operates globally, providing training and support to healthcare professionals. In the last fiscal year, the company had a market cap of $3419 million, profits of $414 million, revenue of $611 million, and 1907 employees.

more

ANALYSIS: With an Obermatt 360° View of 40 (better than 40% compared with alternatives), overall professional sentiment and financial characteristics for the stock Medacta Group are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Medacta Group. The consolidated Growth Rank has a good rank of 84, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 84% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 69 which means that the company has a financing structure that is safer than 69% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 10 which means that the share price of Medacta Group is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 90% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 30, which means that professional investors are more pessimistic about the stock than for 70% of alternative investment opportunities. ...read more

more
Strongest Rank Value
Weakest Rank Revenue Growth
Country Switzerland
Industry Health Care Equipment
Size Medium
Website medacta.com
Index
SPI
Medacta Group stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 9-Apr-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
10 20 13 41
Growth
84 80 99 71
Safety
Safety
69 41 39 37
Sentiment
30 78 77 32
360° View
360° View
40 54 73 35
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
73 69 46 19
Opinions Change
50 84 79 92
Pro Holdings
n/a 65 59 47
Market Pulse
23 57 68 12
Sentiment
30 78 77 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
10 20 13 41
Growth
84 80 99 71
Safety Safety
69 41 39 37
Combined
60 45 52 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
11 15 16 31
Price vs. Earnings (P/E)
13 21 21 44
Price vs. Book (P/B)
12 6 1 14
Dividend Yield
36 44 43 49
Value
10 20 13 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
92 85 75 65
Profit Growth
45 81 91 64
Capital Growth
54 37 56 45
Stock Returns
78 62 91 69
Growth
84 80 99 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
47 39 40 26
Refinancing
63 34 31 33
Liquidity
75 75 56 52
Safety Safety
69 41 39 37

Similar Stocks

Discover high‑ranked alternatives to Medacta Group and broaden your portfolio horizons.

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Philips

AEX:PHIA
Country: Netherlands
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Fresenius

GER:FRE
Country: Germany
Industry: Health Care Services
Size: X-Large
Full Stock Analysis

DKSH

SWX:DKSH
Country: Switzerland
Industry: Trading & Distribution
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The company has high growth and safe financing but is expensive (low Value Rank) and has low market sentiment. This is a warning that the stock may be too expensive. This is for an experienced growth investor willing to risk overpaying, but only after conducting thorough research on future growth potential.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews